USFDA14 May 2026, 11:12 am
Alembic Pharma Receives EIR from USFDA for Karakhadi Injectable Facility
AI Summary
Alembic Pharmaceuticals Ltd has received an Establishment Inspection Report (EIR) from the USFDA for its Injectable Facility (F-III) located at Karakhadi. The USFDA inspection was conducted from February 9, 2026, to February 18, 2026, and the EIR was received on May 13, 2026.
Key Highlights
- Alembic Pharma received EIR from USFDA for its Karakhadi Injectable Facility (F-III).
- The USFDA inspection occurred from February 9 to February 18, 2026.
- The Establishment Inspection Report (EIR) was received on May 13, 2026.